As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...
Mario Hose
|
December 16, 2024
|
By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research
|
December 11, 2024
|
The following is a transcription of the above video, and The Market Online has edited it for clarity . Nextleaf Solutions (CSE:OILS) , is a debt-free cannabis processor known for its multi patented, scalable extraction technology. The company offers a diverse portfo...
Coreena Robertson
|
November 12, 2024
|
“Sell in May and go away” is a theme investors and stock traders know well, and during this quieter month of June ahead of summer, some public Canadian companies have been engaging in serious business. This week, we saw the TSX hit a one-month ...
Jonathon Brown
|
June 6, 2024
|
Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...
Stefan Feulner
|
May 22, 2024
|
The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon
|
April 11, 2024
|
Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson
|
November 6, 2023
|
Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon
|
September 19, 2023
|
Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...
Jonathon Brown
|
May 4, 2023
|
Full Circle Lithium has strategically positioned itself with a team who has 70-years of experience. Armed with a diversified portfolio of feedstock, Full Circle Lithium has up to 2,000 tonnes of capacity which it plans on filling before expanding. The company also has pro...
Brieanna McCutcheon
|
May 1, 2023
|